Stephen Hahn, FDA commissioner (Alex Brandon/AP Images)
August 31, 2020 06:38 AM EDTUpdated 09:54 AM
Coronavirus

Covid-19 roundup: Most Amer­i­cans wor­ry pol­i­tics is put be­fore sci­ence amid vac­cine rush; Dai­ichi Sankyo fur­thers mR­NA shot R&D

John Carroll

Editor & Founder

Max Gelman

Senior Editor

Amber Tong

The re­cent turn of events be­tween the White House and the FDA is cast­ing se­ri­ous doubts on the Covid-19 vac­cine ap­proval process among Amer­i­cans, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times